Prostate Embolization for Benign Prostatic Hyperplasia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Benign Prostatic Hyperplasia
Interventions
DEVICE

Prostatic Embolization with Embosphere Micropsheres

"Each patient will have a selective internal iliac arteriogram, and as necessary, an arteriogram of the anterior division of the internal iliac artery performed to identify the prostatic arterial supply. This typically arises from the inferior vesicle artery (also known as the prostatic artery), but may have supply from the superior vesicle, the internal pudendal or obturator branches as well.~The prostatic arteries will be selected using standard micro-catheter technique. Embolization of the prostate will be performed with 300 to 500 um sized TAGM (Embosphere® Microspheres, Merit Medical, South Jordan, UT). The embolization endpoint will be absence of the normal blush of the prostate on post embolization angiography and stasis of flow in the prostate arteries."

Trial Locations (1)

20007

MedStar Georgetown University Hospital, Washington D.C.

All Listed Sponsors
lead

James B. Spies, MD

OTHER

NCT01924988 - Prostate Embolization for Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter